Anna Shmagel

Featured in: Favicon

biomedcentral.com Favicon

jrheum.org Favicon

onlinelibrary.wiley.com Favicon

arthritis-research.biomedcentral.com

Articles

Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients with Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐label, Phase 1 Trial

Nov 15, 2024 | acrjournals.onlinelibrary.wiley.com | Hermine I Brunner |Anna Shmagel |Gerd Horneff |Ivan Foeldvari

Supporting Information Filename Description acr25465-sup-0001-Disclosureform.pdfPDF document, 1.7 MB Disclosure Form acr25465-sup-0002-Supinfo.pdfPDF document, 290.8 KB Appendix S1: Supporting Information
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)

Jul 1, 2024 | jrheum.org | Gerd R Burmester |John R.P. Tesser |Anna Shmagel |Yanxi Liu

Key Indexing Terms:arthritisclinical trialsRheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects joints, causes progressive bone and cartilage damage, and impairs quality of life if treated inadequately.1,2 The primary goal of RA therapy is to achieve sustained remission or low disease activity (LDA).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →